shakespeare surgery ltd. Company Information
Company Number
04715193
Next Accounts
30 days late
Shareholders
timothy mark dalton
mausumi roy
View AllGroup Structure
View All
Industry
General medical practice activities
Registered Address
c/o johnson tidsall & co, 81 burton road, derby, derbyshire, DE1 1TJ
Website
www.shakespearesurgery.co.ukshakespeare surgery ltd. Estimated Valuation
Pomanda estimates the enterprise value of SHAKESPEARE SURGERY LTD. at £19.7k based on a Turnover of £41.2k and 0.48x industry multiple (adjusted for size and gross margin).
shakespeare surgery ltd. Estimated Valuation
Pomanda estimates the enterprise value of SHAKESPEARE SURGERY LTD. at £389.1k based on an EBITDA of £101.2k and a 3.85x industry multiple (adjusted for size and gross margin).
shakespeare surgery ltd. Estimated Valuation
Pomanda estimates the enterprise value of SHAKESPEARE SURGERY LTD. at £1.5m based on Net Assets of £565.2k and 2.73x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Shakespeare Surgery Ltd. Overview
Shakespeare Surgery Ltd. is a live company located in derby, DE1 1TJ with a Companies House number of 04715193. It operates in the general medical practice activities sector, SIC Code 86210. Founded in March 2003, it's largest shareholder is timothy mark dalton with a 34.2% stake. Shakespeare Surgery Ltd. is a mature, micro sized company, Pomanda has estimated its turnover at £41.2k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Shakespeare Surgery Ltd. Health Check
Pomanda's financial health check has awarded Shakespeare Surgery Ltd. a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
5 Weak
Size
annual sales of £41.2k, make it smaller than the average company (£1.7m)
- Shakespeare Surgery Ltd.
£1.7m - Industry AVG
Growth
3 year (CAGR) sales growth of -56%, show it is growing at a slower rate (7%)
- Shakespeare Surgery Ltd.
7% - Industry AVG
Production
with a gross margin of 41.2%, this company has a comparable cost of product (41.2%)
- Shakespeare Surgery Ltd.
41.2% - Industry AVG
Profitability
an operating margin of 245.7% make it more profitable than the average company (3.9%)
- Shakespeare Surgery Ltd.
3.9% - Industry AVG
Employees
with 1 employees, this is below the industry average (20)
- Shakespeare Surgery Ltd.
20 - Industry AVG
Pay Structure
on an average salary of £32.6k, the company has an equivalent pay structure (£32.6k)
- Shakespeare Surgery Ltd.
£32.6k - Industry AVG
Efficiency
resulting in sales per employee of £41.2k, this is less efficient (£81.3k)
- Shakespeare Surgery Ltd.
£81.3k - Industry AVG
Debtor Days
it gets paid by customers after 17 days, this is earlier than average (41 days)
- Shakespeare Surgery Ltd.
41 days - Industry AVG
Creditor Days
its suppliers are paid after 161 days, this is slower than average (27 days)
- Shakespeare Surgery Ltd.
27 days - Industry AVG
Stock Days
it holds stock equivalent to 38 days, this is more than average (10 days)
- Shakespeare Surgery Ltd.
10 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 383 weeks, this is more cash available to meet short term requirements (44 weeks)
383 weeks - Shakespeare Surgery Ltd.
44 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.3%, this is a lower level of debt than the average (54.6%)
12.3% - Shakespeare Surgery Ltd.
54.6% - Industry AVG
SHAKESPEARE SURGERY LTD. financials
Shakespeare Surgery Ltd.'s latest turnover from March 2023 is estimated at £41.2 thousand and the company has net assets of £565.2 thousand. According to their latest financial statements, we estimate that Shakespeare Surgery Ltd. has 1 employee and maintains cash reserves of £586.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 11 | 11 | 11 | 11 | 11 | 10 | 10 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 520 | 584 | 664 | 765 | 891 | 1,048 | 1,590 | 1,988 | 2,306 | 2,701 | 2,919 | 3,259 | 3,237 | 4,046 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 53,329 | 49,855 | 52,485 | 23,777 | 23,777 | 23,777 | 23,777 | 23,777 | 24,446 | 24,289 | 24,208 | 23,215 | 25,980 | 25,367 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 53,849 | 50,439 | 53,149 | 24,542 | 24,668 | 24,825 | 25,367 | 25,765 | 26,752 | 26,990 | 27,127 | 26,474 | 29,217 | 29,413 |
Stock & work in progress | 2,562 | 2,147 | 1,328 | 1,174 | 1,497 | 1,573 | 1,616 | 1,284 | 873 | 723 | 538 | 472 | 459 | 197 |
Trade Debtors | 1,926 | 1,386 | 725 | 0 | 0 | 0 | 0 | 0 | 222 | 222 | 217 | 26,471 | 42,150 | 43,862 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 246 | 717 | 525 | 525 | 472 | 1,035 | 1,247 | 1,243 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 586,120 | 479,249 | 367,972 | 447,247 | 421,926 | 421,731 | 424,138 | 420,840 | 397,756 | 411,776 | 404,982 | 239,634 | 165,964 | 144,805 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 590,854 | 483,499 | 370,550 | 448,946 | 423,895 | 424,339 | 427,001 | 423,367 | 398,851 | 412,721 | 405,737 | 266,577 | 208,573 | 188,864 |
total assets | 644,703 | 533,938 | 423,699 | 473,488 | 448,563 | 449,164 | 452,368 | 449,132 | 425,603 | 439,711 | 432,864 | 293,051 | 237,790 | 218,277 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 10,725 | 4,709 | 4,759 | 2,908 | 46,313 | 46,922 | 46,851 | 46,177 | 166,195 | 179,153 | 177,368 | 105,729 | 67,299 | 53,998 |
Group/Directors Accounts | 538 | 1,264 | 125 | 227 | 190 | 379 | 672 | 122 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 68,262 | 64,475 | 37,343 | 126,163 | 113,470 | 118,016 | 126,596 | 120,351 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 79,525 | 70,448 | 42,227 | 129,298 | 159,973 | 165,317 | 174,119 | 166,650 | 166,195 | 179,153 | 177,368 | 105,729 | 67,299 | 53,998 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 79,525 | 70,448 | 42,227 | 129,298 | 159,973 | 165,317 | 174,119 | 166,650 | 166,195 | 179,153 | 177,368 | 105,729 | 67,299 | 53,998 |
net assets | 565,178 | 463,490 | 381,472 | 344,190 | 288,590 | 283,847 | 278,249 | 282,482 | 259,408 | 260,558 | 255,496 | 187,322 | 170,491 | 164,279 |
total shareholders funds | 565,178 | 463,490 | 381,472 | 344,190 | 288,590 | 283,847 | 278,249 | 282,482 | 259,408 | 260,558 | 255,496 | 187,322 | 170,491 | 164,279 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 64 | 80 | 101 | 126 | 157 | 385 | 398 | 318 | 395 | 490 | 715 | 781 | 809 | 1,011 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | ||||||||||||||
Stock | 415 | 819 | 154 | -323 | -76 | -43 | 332 | 411 | 150 | 185 | 66 | 13 | 262 | 197 |
Debtors | 69 | 853 | 725 | 53 | -563 | -212 | 4 | 1,021 | 0 | 5 | -26,254 | -15,679 | -1,712 | 43,862 |
Creditors | 6,016 | -50 | 1,851 | -43,405 | -609 | 71 | 674 | -120,018 | -12,958 | 1,785 | 71,639 | 38,430 | 13,301 | 53,998 |
Accruals and Deferred Income | 3,787 | 27,132 | -88,820 | 12,693 | -4,546 | -8,580 | 6,245 | 120,351 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 3,474 | -2,630 | 28,708 | 0 | 0 | 0 | 0 | -669 | 157 | 81 | 993 | -2,765 | 613 | 25,367 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -726 | 1,139 | -102 | 37 | -189 | -293 | 550 | 122 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | 106,871 | 111,277 | -79,275 | 25,321 | 195 | -2,407 | 3,298 | 23,084 | -14,020 | 6,794 | 165,348 | 73,670 | 21,159 | 144,805 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 106,871 | 111,277 | -79,275 | 25,321 | 195 | -2,407 | 3,298 | 23,084 | -14,020 | 6,794 | 165,348 | 73,670 | 21,159 | 144,805 |
shakespeare surgery ltd. Credit Report and Business Information
Shakespeare Surgery Ltd. Competitor Analysis
Perform a competitor analysis for shakespeare surgery ltd. by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in DE1 area or any other competitors across 12 key performance metrics.
shakespeare surgery ltd. Ownership
SHAKESPEARE SURGERY LTD. group structure
Shakespeare Surgery Ltd. has no subsidiary companies.
Ultimate parent company
SHAKESPEARE SURGERY LTD.
04715193
shakespeare surgery ltd. directors
Shakespeare Surgery Ltd. currently has 5 directors. The longest serving directors include Dr Timothy Dalton (Mar 2004) and Dr Timothy Dalton (Mar 2004).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Timothy Dalton | 54 years | Mar 2004 | - | Director | |
Dr Timothy Dalton | 54 years | Mar 2004 | - | Director | |
Dr Mansumi Roy | England | 49 years | Jul 2007 | - | Director |
Dr Adam Jolles | United Kingdom | 50 years | Apr 2010 | - | Director |
Dr Sean Walsh | United Kingdom | 32 years | Apr 2023 | - | Director |
P&L
March 2023turnover
41.2k
-86%
operating profit
101.1k
0%
gross margin
41.2%
-3.15%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
565.2k
+0.22%
total assets
644.7k
+0.21%
cash
586.1k
+0.22%
net assets
Total assets minus all liabilities
shakespeare surgery ltd. company details
company number
04715193
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
March 2003
age
22
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2023
previous names
affrox limited (September 2004)
accountant
JOHNSON TIDSALL LIMITED
auditor
-
address
c/o johnson tidsall & co, 81 burton road, derby, derbyshire, DE1 1TJ
Bank
-
Legal Advisor
-
shakespeare surgery ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to shakespeare surgery ltd..
shakespeare surgery ltd. Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SHAKESPEARE SURGERY LTD.. This can take several minutes, an email will notify you when this has completed.
shakespeare surgery ltd. Companies House Filings - See Documents
date | description | view/download |
---|